Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Gemcitabine in Pancreatic Cancer
NCT01547260Phase 2Completed
- Sponsor
- Maria Liljefors AB
- Start
- Oct 2009
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in pancreatic ductal adenocarcinoma (PDAC), sponsored by Maria Liljefors AB. Started Oct 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01547260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01547260.